What is Mounjaro?
Mounjaro is an effective weight loss treatment. It works by curbing your appetite and acts as an aid for healthy weight loss. The active ingredient in Mounjaro is Trizepatide. Trizepatide works by mimicking the effect that two of your natural hormones play in making you feel full and energised. This sends signals to your brain which make you feel full, resulting in lower calorie intake throughout the day.
Dosage
Mounjaro is available in 6 different dosages:
- 2.5mg
- 5mg
- 7.5mg
- 10mg
- 12.5mg
- 15mg
Typically, you start on a dose of 2.5mg, which is taken weekly throughout the first month of treatment. If you do not feel any side effects, the dosage will increase by 2.5mg every month until the maintenance dose is achieved. The maintenance dose is typically 15mg however, this may vary. Clinicians will determine the appropriate maintenance dose for you
How to take Mounjaro
You administer Mounjaro once a week. This is done by a pen injection in your stomach, upper arm or thigh.
It is a simple process that, if needed, your clinician will guide you through.
What are the side effects?
Your clinician will start you on the lowest dose of Mounjaro, if you are new to the treatment. If you have been taking the medication, and wish to administer a higher or lower dosage, you will need to provide evidence of your prescription.
This is to limit the potential side effects, which can include:
- Nausea
- Diarrhoea
- Vomiting
- Constipation
- Stomach Pain
- Indigestion
Side effects are most common when you start taking the medication, or increase your dosage. This is normal, and side effects should go away once your body has adjusted to the medication.
Expected weight loss
Mounjaro has been proven to be safe through clinical trials. A study* found that, when combined with regular exercise and a balanced diet, Mounjaro helped patients lose 22%* of their overall weight, making it one of the most effective weight loss treatments in the market for obesity.
*Based on 15mg tirzepatide over 72 weeks. Jastreboff, Aronne, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine (2022).
Safe use of Mounjaro:
We provide a full safety and information pack with your medication. We recommend that you read this thoroughly prior to takin any medication.
